Chronic Obstructive Lung Disease: Clinical Trials

4 trials for Chronic Obstructive Lung Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 withdrawn. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Terminated 1, Withdrawn 1

Follow Chronic Obstructive Lung Disease: new trials by email Literature Review of Chronic Obstructive Lung Disease trials Research Report on Chronic Obstructive Lung Disease

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Symbicort ® on GR in Sputum in COPD
Symbicort® total dose 400ug/12ug, Symbicort® total dose 800ug/24ug, Formoterol 24ug - Chronic Obstructive Lung Disease
Phase 4CompletedImperial College London312013-01-012020-11-23
The Pulmonary Protection Trial
Perfusion of the lungs, HTK Custodiol, Standard ECC - Chronic Obstructive Lung Disease
Phase 4CompletedCopenhagen University Hospital, Rigshospitalet902012-07-012014-04-25
Effects of Symbicort on the Ventilatory Kinematics
Budesonide, Symbicort - Chronic Obstructive Lung Disease
Phase 4TerminatedColumbia University92012-03-012016-09-02
Vitamin D and Chronic Obstructive Lung Disease
Vitamin D (D3, cholecalciferol), Placebo (cellulose) - Chronic Obstructive Lung Disease
Phase 4WithdrawnJorgen Vestbo2011-09-012013-04-09

Narrower conditions

Pulmonary Disease, Chronic Obstructive (4)

Broader conditions

Chronic Disease (4)  ·  Disease Attributes (4)  ·  Lung Diseases (4)  ·  Lung Diseases, Obstructive (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Respiratory Tract Diseases (4)

Interventions

Bretschneider cardioplegic solution (1)  ·  Budesonide (1)  ·  Budesonide, Formoterol Fumarate Drug Combination (1)  ·  Cellulose (1)  ·  Cholecalciferol (1)  ·  Formoterol Fumarate (1)  ·  Vitamin D (1)

Sponsors

Columbia University (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Imperial College London (1)  ·  Jorgen Vestbo (1)

Countries

Denmark (2)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Matthew Bartels, MD, MPH (1)  ·  Omar S Usmani, PhD (1)

Results publications

PMID 23363494, PMID 25539792, PMID 27651908, PMID 30879046